|
Published by: BioPlan Associates, Inc.
Published: Jan. 1, 2008 - 766 Pages
Table of Contents
- PART 1: Introduction
- Chapter 1 Prospects for Modern Biotechnology in India
- PART 2: State of India's Life Sciences Industry
- Chapter 2 A Window into India's Biopharma Sector
- Chapter 3 Indian Biopharmaceutical System and Policies
- Chapter 4 Government Support for Biotech and Biopharmaceuticals Industry
- Chapter 5 Biopharmaceutical Products in India.
- Chapter 6 Biogeneric Manufacturing in India
- Chapter 7 Biopharmaceutical Market Situation.
- Chapter 8 The Contract Research Industry in India
- Chapter 9 Regulatory Landscape for Clinical Trials in India
- INDIA BRIEF 1 Pre-Clinical and Clinical Trial in India
- Chapter 10 Life Sciences Education in India
- PART 3: Scientific Issues in India
- Chapter 11 Vaccine Industry in India
- Chapter 12 Development of Plasma-Derived Biopharmaceuticals in India: Challenges and Opportunities
- Chapter 13 Bioprocess Expression and Production Technologies in India
- INDIA BRIEF 2 Technology Transfer: Impact and Importance for Indian Biotechnology Growth
- Chapter 14 Application of Recent Advances in Immunology for Developing Novel Biotherapeutics in India
- Chapter 15 Early-stage Key R&D Components for Successful Development of Protein Therapeutics
- Chapter 16 Understanding Ayurveda Medicine
- PART 4: Biobusiness in India
- Chapter 17 Biopharmaceutical Outsourcing: A Overview--India and China
- Chapter 18 Biopharmaceutical Research Collaborations between India and the West: Prospective Partnerships
- Chapter 19 Outsourcing R&D to India
- INDIA BRIEF 3 Outsourcing Biopharma R&D to India
- Chapter 20 Venture Capital in India Today
- Organizations Represented (Authors)
- Amgen, Inc.
- Apothecaries Ltd.
- beòcarta Ltd.
- Bharat Biotech International Ltd.
- BioPlan Associates, Inc.
- Biospectrum Asia
- Cadila Pharmaceuticals Ltd.
- CanBiotech
- Celestial Biologicals Ltd
- Chiltern International Private Ltd.
- Dow AgroSciences LLC
- Endocrine Technology, LLC
- Finston Consulting, LLC
- GAEA Resources Inc.
- Health Interactions
- J. Sagar Associates
- John Curling Consulting AB
- M J Biopharm Pvt. Ltd.
- Magnetical
- National Institute of Health
- National Institute of Science Technology and Development Studies
- Neo BioMed Services
- ProMetic BioTherapeutics, Inc.
- Serum Institute of India Ltd.
- Strategic Manufacturing Worldwide, Inc.
- Uniformed Services University of the Health Sciences.
- Reviewers from:
- Bharat Biotech, India
- Biotech Consultant LLC, USA
- Cadila Pharmaceuticals Ltd., India
- Excel Life Sciences, Inc., USA
- Falconridge Associates, Inc.
- Institute of Bioinformatics and Applied Biotechnology (IBAB), India
- John Curling Consulting, Sweden
- Madhav Institute of Technology and Science, India
- National Institute of Science Technology and Development Studies, India
- Newport Biotech
- Strategic Manufacturing Worldwide, Inc.
- University of Illinois, USA
- University of Iowa, USA
AbstractINDIA is rapidly becoming a vital, mature partner within international bio/pharmaceutical markets. The new peer-reviewed, joint Society for Industrial Microbiology publication, Advances in Biopharmaceutical Technology in India, indicates that Indian companies and suppliers plan to achieve a 10% global biopharmaceutical market share within the foreseeable future.
This study provides an in-depth view of the biopharmaceutical industry in India. It describes the current state of technology, partnership opportunities, science aspects, and general business practices. Readers will find accurate, peer-reviewed analysis of business opportunities to help them create effective India Strategies.
By the Numbers:
- 35 Internationally Recognized Authors
- 766 Pages
- 20 Chapters
- 14 Peer reviewers
- 1,178 References
- 118 Tables and 49 Figures
What You'll Get:
- Expert, unbiased, analysis: 35 internationally recognized authors, sponsored by Society for Industrial Microbiology
- Peer-reviewed: Editorial board and review ensures relevance, accuracy, and substance.
- Unparalleled access to experts: Purchasers have unique access to study contributors and authors.
- Fresh, relevant information: Subject matter experts combine their in-depth knowledge with current, primary data.
India is investing heavily in technologies and education, and will be one of the world's largest markets for vaccines and biopharmaceuticals.
This comprehensive study of the science and business of biopharmaceuticals in India: Advan ces in Biopharmaceutical Technology in India provides answers, from world- recognized subject matter experts in India, the US, and Europe.
Advances in Biopharmaceutical Technology in INDIA:
describes the Indian industry, organizations, and government plans and goals. It details successes, problems, and gaps. The study covers issues critical to biomanufacturers, CMOs, CROs, and suppliers, and describes the current state of technology, partnership opportunities, and general business practices.
A ready reference for all aspects of biopharmaceuticals in India
India has one of the world's fastest growing economies, and the second-largest population, with 1.1 billion people. Its middle class is the engine providing the economic power to support an expanding domestic healthcare industry. Learn how to take advantage of the opportunities that exist for organizations that establish solid business and scientific strategies.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|
